Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke - Cellular and Molecular Neurobiology
- ️Wang, Wei
- ️Fri Oct 30 2020
References
Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 37(1):13–25. https://doi.org/10.1016/j.nbd.2009.07.030
Abeysinghe H, Roulston CL (2018) A Complete guide to using the endothelin-1 model of Stroke in conscious rats for acute and long-term recovery studies. Methods Mol Biol 1717:115–133. https://doi.org/10.1007/978-1-4939-7526-6_10
Abumiya T, Yokota C, Kuge Y, Minematsu K (2005) Aggravation of hemorrhagic transformation by early intraarterial infusion of low-dose vascular endothelial growth factor after transient focal cerebral ischemia in rats. Brain Res 1049(1):95–103. https://doi.org/10.1016/j.brainres.2005.05.011
Adriani G, Ma D, Pavesi A, Kamm RD, Goh EL (2017) A 3D neurovascular microfluidic model consisting of neurons, astrocytes and cerebral endothelial cells as a blood-brain barrier. Lab Chip 17(3):448–459. https://doi.org/10.1039/c6lc00638h
Alawieh A, Andersen M, Adkins DL, Tomlinson S (2018) Acute complement inhibition potentiates neurorehabilitation and enhances tPA-mediated neuroprotection. J Neurosci 38(29):6527–6545. https://doi.org/10.1523/JNEUROSCI.0111-18.2018
Alawieh A, Elvington A, Zhu H, Yu J, Kindy MS, Atkinson C, Tomlinson S (2015) Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement. J Neuroinflamm 12:247. https://doi.org/10.1186/s12974-015-0464-8
Alessi MC, Gaudin C, Grosjean P, Martin V, Timsit S, Mahagne MH, Larrue V, Sibon I, Zuber M, Brouns R, Montaner J, Castellanos M, Donazzolo Y, Cho TH, Suissa L, Mechtouff L, Derex L, Suchon P, Mezzapesa A, Nighoghossian N (2016) Changes in activated thrombin-activatable fibrinolysis inhibitor levels following thrombolytic therapy in ischemic stroke patients correlate with clinical outcome. Cerebrovasc Dis 42(5–6):404–414. https://doi.org/10.1159/000447722
Andrabi SS, Parvez S, Tabassum H (2019) Ischemic stroke and mitochondria: mechanisms and targets. Protoplasma. https://doi.org/10.1007/s00709-019-01439-2
Andreou AP, Efthymiou M, Yu Y, Watts HR, Noormohamed FH, Ma D, Lane DA, Crawley JT (2015) Protective effects of non-anticoagulant activated protein C variant (D36A/L38D/A39V) in a murine model of ischaemic stroke. PLoS ONE 10(4):e0122410. https://doi.org/10.1371/journal.pone.0122410
Anrather J, Iadecola C (2016) Inflammation and stroke: an overview. Neurotherapeutics 13(4):661–670. https://doi.org/10.1007/s13311-016-0483-x
Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR (2009) VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci USA 106(6):1977–1982. https://doi.org/10.1073/pnas.0808698106
Atochin DN, Murciano JC, Gürsoy-Ozdemir Y, Krasik T, Noda F, Ayata C, Dunn AK, Moskowitz MA, Huang PL, Muzykantov VR (2004) Mouse model of microembolic stroke and reperfusion. Stroke 35(9):2177–2182. https://doi.org/10.1161/01.STR.0000137412.35700.0e
Bang OY, Saver JL, Kim SJ, Kim GM, Chung CS, Ovbiagele B, Lee KH, Liebeskind DS, UCLA-Samsung Stroke Collaborators (2011) Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke 42(8):2235–2239. https://doi.org/10.1161/STROKEAHA.110.604603
Barreto AD, Alexandrov AV, Lyden P, Lee J, Martin-Schild S, Shen L, Wu TC, Sisson A, Pandurengan R, Chen Z, Rahbar MH, Balucani C, Barlinn K, Sugg RM, Garami Z, Tsivgoulis G, Gonzales NR, Savitz SI, Mikulik R, Demchuk AM, Grotta JC (2012) The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study. Stroke 43(3):770–775. https://doi.org/10.1161/STROKEAHA.111.625574
Barreto AD, Ford GA, Shen L, Pedroza C, Tyson J, Cai C, Rahbar MH, Grotta JC, ARTSS-2 Investigators (2017) Randomized, multicenter trial of ARTSS-2 (argatroban with recombinant tissue plasminogen activator for acute stroke). Stroke 48(6):1608–1616. https://doi.org/10.1161/STROKEAHA.117.016720
Basic Kes V, Simundic AM, Nikolac N, Topic E, Demarin V (2008) Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome. Clin Biochem 41(16–17):1330–1334. https://doi.org/10.1016/j.clinbiochem.2008.08.080
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2017) Heart Disease and Stroke Statistics-2017 Update: a report from the American Heart Association. Circulation 135(10):e146–146e603
Berger C, Fiorelli M, Steiner T, Schäbitz WR, Bozzao L, Bluhmki E, Hacke W, von Kummer R (2001) Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic. Stroke 32(6):1330–1335. https://doi.org/10.1161/01.str.32.6.1330
Brennan AM, Suh SW, Won SJ, Narasimhan P, Kauppinen TM, Lee H, Edling Y, Chan PH, Swanson RA (2009) NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat Neurosci 12(7):857–863. https://doi.org/10.1038/nn.2334
Cai B, Wang N (2016) Large animal stroke models vs. rodent stroke models, pros and cons, and combination. Acta Neurochir Suppl 121:77–81. https://doi.org/10.1007/978-3-319-18497-5_13
Campos F, Qin T, Castillo J, Seo JH, Arai K, Lo EH, Waeber C (2013) Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model. Stroke 44(2):505–511. https://doi.org/10.1161/STROKEAHA.112.679043
Campos M, García-Bonilla L, Hernández-Guillamon M, Barceló V, Morancho A, Quintana M, Rubiera M, Rosell A, Montaner J (2013) Combining statins with tissue plasminogen activator treatment after experimental and human stroke: a safety study on hemorrhagic transformation. CNS Neurosci Ther 19(11):863–870. https://doi.org/10.1111/cns.12181
Canfield SG, Stebbins MJ, Faubion MG, Gastfriend BD, Palecek SP, Shusta EV (2019) An isogenic neurovascular unit model comprised of human induced pluripotent stem cell-derived brain microvascular endothelial cells, pericytes, astrocytes, and neurons. Fluids Barriers CNS 16(1):25. https://doi.org/10.1186/s12987-019-0145-6
Canfield SG, Stebbins MJ, Morales BS, Asai SW, Vatine GD, Svendsen CN, Palecek SP, Shusta EV (2017) An isogenic blood-brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells. J Neurochem 140(6):874–888. https://doi.org/10.1111/jnc.13923
Carden DL, Granger DN (2000) Pathophysiology of ischaemia-reperfusion injury. J Pathol 190(3):255–266
Castellanos M, Leira R, Serena J, Blanco M, Pedraza S, Castillo J, Dávalos A (2004) Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. Stroke 35(7):1671–1676. https://doi.org/10.1161/01.STR.0000131656.47979.39
Castellanos M, Leira R, Serena J, Pumar JM, Lizasoain I, Castillo J, Dávalos A (2003) Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 34(1):40–46
Castellanos M, Sobrino T, Millán M, García M, Arenillas J, Nombela F, Brea D, Perez de la Ossa N, Serena J, Vivancos J, Castillo J, Dávalos A (2007) Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study. Stroke 38(6):1855–1859. https://doi.org/10.1161/STROKEAHA.106.481556
Chamorro Á, Amaro S, Castellanos M, Gomis M, Urra X, Blasco J, Arenillas JF, Román LS, Muñoz R, Macho J, Cánovas D, Marti-Fabregas J, Leira EC, Planas AM, URICO-ICTUS Investigators (2017) Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy. Int J Stroke 12(4):377–382. https://doi.org/10.1177/1747493016684354
Chapman KZ, Dale VQ, Dénes A, Bennett G, Rothwell NJ, Allan SM, McColl BW (2009) A rapid and transient peripheral inflammatory response precedes brain inflammation after experimental stroke. J Cereb Blood Flow Metab 29(11):1764–1768. https://doi.org/10.1038/jcbfm.2009.113
Charidimou A, Nicoll JA, McCarron MO (2015) Thrombolysis-related intracerebral hemorrhage and cerebral amyloid angiopathy: accumulating evidence. Front Neurol 6:99. https://doi.org/10.3389/fneur.2015.00099
Chen C, Ostrowski RP, Zhou C, Tang J, Zhang JH (2010) Suppression of hypoxia-inducible factor-1alpha and its downstream genes reduces acute hyperglycemia-enhanced hemorrhagic transformation in a rat model of cerebral ischemia. J Neurosci Res 88(9):2046–2055. https://doi.org/10.1002/jnr.22361
Chen F, Suzuki Y, Nagai N, Sun X, Wang H, Yu J, Marchal G, Ni Y (2007) Microplasmin and tissue plasminogen activator: comparison of therapeutic effects in rat stroke model at multiparametric MR imaging. Radiology 244(2):429–438. https://doi.org/10.1148/radiol.2442061316
Chen H, Chen X, Luo Y, Shen J (2018) Potential molecular targets of peroxynitrite in mediating blood-brain barrier damage and haemorrhagic transformation in acute ischaemic stroke with delayed tissue plasminogen activator treatment. Free Radic Res 52(11–12):1220–1239. https://doi.org/10.1080/10715762.2018.1521519
Chen HS, Chen X, Li WT, Shen JG (2018) Targeting RNS/caveolin-1/MMP signaling cascades to protect against cerebral ischemia-reperfusion injuries: potential application for drug discovery. Acta Pharmacol Sin 39(5):669–682. https://doi.org/10.1038/aps.2018.27
Chen QF, Liu YY, Pan CS, Fan JY, Yan L, Hu BH, Chang X, Li Q, Han JY (2018a) Angioedema and hemorrhage after 4.5-hour tPA (tissue-type plasminogen activator) thrombolysis ameliorated by T541 via restoring brain microvascular integrity. Stroke 49(9):2211–2219
Chen R, Lai UH, Zhu L, Singh A, Ahmed M, Forsyth NR (2018) Reactive Oxygen Species Formation in the Brain at Different Oxygen Levels: The Role of Hypoxia Inducible Factors. Front Cell Dev Biol 6:132. https://doi.org/10.3389/fcell.2018.00132
Chen S, Lu X, Zhang W, Han Z, Yang W, Huang X, Jin X, Wang Z, Liang H, Qiu W, Cheng J, Shao B (2016) Does prior antiplatelet treatment increase the risk of hemorrhagic transformation and unfavorable outcome on day 90 after intravenous thrombolysis in acute ischemic stroke patients. J Stroke Cerebrovasc Dis 25(6):1366–1370. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.01.038
Chen TY, Lee MY, Chen HY, Kuo YL, Lin SC, Wu TS, Lee EJ (2006) Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice. J Pineal Res 40(3):242–250. https://doi.org/10.1111/j.1600-079X.2005.00307.x
Chen XM, Chen HS, Xu MJ, Shen JG (2013) Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury. Acta Pharmacol Sin 34(1):67–77. https://doi.org/10.1038/aps.2012.82
Chen Y, Zhu W, Zhang W, Libal N, Murphy SJ, Offner H, Alkayed NJ (2015) A novel mouse model of thromboembolic stroke. J Neurosci Methods 256:203–211. https://doi.org/10.1016/j.jneumeth.2015.09.013
Cheng T, Petraglia AL, Li Z, Thiyagarajan M, Zhong Z, Wu Z, Liu D, Maggirwar SB, Deane R, Fernández JA, LaRue B, Griffin JH, Chopp M, Zlokovic BV (2006) Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Nat Med 12(11):1278–1285. https://doi.org/10.1038/nm1498
Christoforidis GA, Karakasis C, Mohammad Y, Caragine LP, Yang M, Slivka AP (2009) Predictors of hemorrhage following intra-arterial thrombolysis for acute ischemic stroke: the role of pial collateral formation. AJNR Am J Neuroradiol 30(1):165–170. https://doi.org/10.3174/ajnr.A1276
Cocho D, Borrell M, Martí-Fàbregas J, Montaner J, Castellanos M, Bravo Y, Molina-Porcel L, Belvís R, Díaz-Manera JA, Martínez-Domeño A, Martínez-Lage M, Millán M, Fontcuberta J, Martí-Vilalta JL (2006) Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator. Stroke 37(4):996–999. https://doi.org/10.1161/01.STR.0000206461.71624.50
Cohen P, Goedert M (2004) GSK3 inhibitors: development and therapeutic potential. Nat Rev Drug Discov 3(6):479–487. https://doi.org/10.1038/nrd1415
Colak G, Filiano AJ, Johnson GV (2011) The application of permanent middle cerebral artery ligation in the mouse. J Vis Exp. https://doi.org/10.3791/3039
Cook DJ, Tymianski M (2012) Nonhuman primate models of stroke for translational neuroprotection research. Neurotherapeutics 9(2):371–379. https://doi.org/10.1007/s13311-012-0115-z
Core A, Pinner N, Bethea B, Starr JA (2019) Timing of anticoagulation in atrial fibrillation status post cardioembolic stroke. J Pharm Pract. https://doi.org/10.1177/0897190019825577
Cotrina ML, Lou N, Tome-Garcia J, Goldman J, Nedergaard M (2017) Direct comparison of microglial dynamics and inflammatory profile in photothrombotic and arterial occlusion evoked stroke. Neuroscience 343:483–494. https://doi.org/10.1016/j.neuroscience.2016.12.012
Couret D, Bourane S, Catan A, Nativel B, Planesse C, Dorsemans AC, Ait-Arsa I, Cournot M, Rondeau P, Patche J, Tran-Dinh A, Lambert G, Diotel N, Meilhac O (2018) A hemorrhagic transformation model of mechanical stroke therapy with acute hyperglycemia in mice. J Comp Neurol 526(6):1006–1016. https://doi.org/10.1002/cne.24386
Cucchiara B, Tanne D, Levine SR, Demchuk AM, Kasner S (2008) A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke. J Stroke Cerebrovasc Dis 17(6):331–333. https://doi.org/10.1016/j.jstrokecerebrovasdis.2008.03.012
Cui X, Chopp M, Zacharek A, Ye X, Roberts C, Chen J (2011) Angiopoietin/Tie2 pathway mediates type 2 diabetes induced vascular damage after cerebral stroke. Neurobiol Dis 43(1):285–292. https://doi.org/10.1016/j.nbd.2011.04.005
Dankbaar JW, Hom J, Schneider T, Cheng SC, Lau BC, van der Schaaf I, Virmani S, Pohlman S, Dillon WP, Wintermark M (2008) Dynamic perfusion CT assessment of the blood-brain barrier permeability: first pass versus delayed acquisition. AJNR Am J Neuroradiol 29(9):1671–1676. https://doi.org/10.3174/ajnr.A1203
Darger B, Gonzales N, Banuelos RC, Peng H, Radecki RP, Doshi PB (2015) Outcomes of patients requiring blood pressure control before thrombolysis with tPA for acute ischemic stroke. West J Emerg Med 16(7):1002–1006. https://doi.org/10.5811/westjem.2015.8.27859
de Haas AH, van Weering HR, de Jong EK, Boddeke HW, Biber KP (2007) Neuronal chemokines: versatile messengers in central nervous system cell interaction. Mol Neurobiol 36(2):137–151. https://doi.org/10.1007/s12035-007-0036-8
del Río-Espínola A, Fernández-Cadenas I, Giralt D, Quiroga A, Gutiérrez-Agulló M, Quintana M, Fernández-Álvarez P, Domingues-Montanari S, Mendióroz M, Delgado P, Turck N, Ruíz A, Ribó M, Castellanos M, Obach V, Martínez S, Freijo MM, Jiménez-Conde J, Cuadrado-Godia E, Roquer J, Chacón P, Martí-Fábregas J, Sánchez JC, Investigators GRECOS, Montaner J (2012) A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke. Ann Neurol 72(5):716–729. https://doi.org/10.1002/ana.23664
del Zoppo GJ, Copeland BR, Anderchek K, Hacke W, Koziol JA (1990) Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction. Stroke 21(4):596–601. https://doi.org/10.1161/01.str.21.4.596
Dela Peña IC, Yang S, Shen G, Fang Liang H, Solak S, Borlongan CV (2018) Extension of tissue plasminogen activator treatment window by granulocyte-colony stimulating factor in a thromboembolic rat model of stroke. Int J Mol Sci. https://doi.org/10.3390/ijms19061635
Desilles JP, Syvannarath V, Ollivier V, Journé C, Delbosc S, Ducroux C, Boisseau W, Louedec L, Di Meglio L, Loyau S, Jandrot-Perrus M, Potier L, Michel JB, Mazighi M, Ho-Tin-Noé B (2017) Exacerbation of thromboinflammation by hyperglycemia precipitates cerebral infarct growth and hemorrhagic transformation. Stroke 48(7):1932–1940. https://doi.org/10.1161/STROKEAHA.117.017080
Dimitrijevic OB, Stamatovic SM, Keep RF, Andjelkovic AV (2006) Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury. J Cereb Blood Flow Metab 26(6):797–810. https://doi.org/10.1038/sj.jcbfm.9600229
Dinapoli VA, Rosen CL, Nagamine T, Crocco T (2006) Selective MCA occlusion: a precise embolic stroke model. J Neurosci Methods 154(1–2):233–238. https://doi.org/10.1016/j.jneumeth.2005.12.026
Dirnagl U (2016) Thomas willis lecture: is translational stroke research broken, and if so, how can we fix it. Stroke 47(8):2148–2153. https://doi.org/10.1161/STROKEAHA.116.013244
Ducruet AF, Zacharia BE, Sosunov SA, Gigante PR, Yeh ML, Gorski JW, Otten ML, Hwang RY, DeRosa PA, Hickman ZL, Sergot P, Connolly ES Jr (2012) Complement inhibition promotes endogenous neurogenesis and sustained anti-inflammatory neuroprotection following reperfused stroke. PLoS ONE 7(6):e38664. https://doi.org/10.1371/journal.pone.0038664
Ebrahim S, Sung J, Song YM, Ferrer RL, Lawlor DA, Davey Smith G (2006) Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study. BMJ 333(7557):22. https://doi.org/10.1136/bmj.38855.610324.80
El Amki M, Lerouet D, Garraud M, Teng F, Beray-Berthat V, Coqueran B, Barsacq B, Abbou C, Palmier B, Marchand-Leroux C, Margaill I (2018) Improved reperfusion and vasculoprotection by the poly(ADP-Ribose)polymerase inhibitor PJ34 after stroke and thrombolysis in mice. Mol Neurobiol 55(12):9156–9168. https://doi.org/10.1007/s12035-018-1063-3
Elvington A, Atkinson C, Zhu H, Yu J, Takahashi K, Stahl GL, Kindy MS, Tomlinson S (2012) The alternative complement pathway propagates inflammation and injury in murine ischemic stroke. J Immunol 189(9):4640–4647. https://doi.org/10.4049/jimmunol.1201904
Engel O, Kolodziej S, Dirnagl U, Prinz V (2011) Modeling stroke in mice—middle cerebral artery occlusion with the filament model. J Vis Exp. https://doi.org/10.3791/2423
Eriguchi M, Yakushiji Y, Tanaka J, Nishihara M, Hara H (2017) Thrombolysis-related multiple lobar hemorrhaging in cerebral amyloid angiopathy with extensive strictly lobar cerebral microbleeding. Intern Med 56(14):1907–1910. https://doi.org/10.2169/internalmedicine.56.8007
Ezan P, André P, Cisternino S, Saubaméa B, Boulay AC, Doutremer S, Thomas MA, Quenech’du N, Giaume C, Cohen-Salmon M (2012) Deletion of astroglial connexins weakens the blood-brain barrier. J Cereb Blood Flow Metab 32(8):1457–1467. https://doi.org/10.1038/jcbfm.2012.45
Fagan SC, Hess DC, Hohnadel EJ, Pollock DM, Ergul A (2004) Targets for vascular protection after acute ischemic stroke. Stroke 35(9):2220–2225. https://doi.org/10.1161/01.STR.0000138023.60272.9e
Fagan SC, Nagaraja TN, Fenstermacher JD, Zheng J, Johnson M, Knight RA (2003) Hemorrhagic transformation is related to the duration of occlusion and treatment with tissue plasminogen activator in a nonembolic stroke model. Neurol Res 25(4):377–382. https://doi.org/10.1179/016164103101201526
Fan X, Lo EH, Wang X (2013) Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats. Stroke 44(3):745–752. https://doi.org/10.1161/STROKEAHA.111.000309
Fan X, Ning M, Lo EH, Wang X (2013) Early insulin glycemic control combined with tPA thrombolysis reduces acute brain tissue damages in a focal embolic stroke model of diabetic rats. Stroke 44(1):255–259. https://doi.org/10.1161/STROKEAHA.112.663476
Fluri F, Schuhmann MK, Kleinschnitz C (2015) Animal models of ischemic stroke and their application in clinical research. Drug Des Devel Ther 9:3445–3454. https://doi.org/10.2147/DDDT.S56071
Foerch C, Wunderlich MT, Dvorak F, Humpich M, Kahles T, Goertler M, Alvarez-Sabín J, Wallesch CW, Molina CA, Steinmetz H, Sitzer M, Montaner J (2007) Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. Stroke 38(9):2491–2495. https://doi.org/10.1161/STROKEAHA.106.480111
Frankowski JC, DeMars KM, Ahmad AS, Hawkins KE, Yang C, Leclerc JL, Doré S, Candelario-Jalil E (2015) Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke. Sci Rep 5:17956. https://doi.org/10.1038/srep17956
García-Culebras A, Palma-Tortosa S, Moraga A, García-Yébenes I, Durán-Laforet V, Cuartero MI, de la Parra J, Barrios-Muñoz AL, Díaz-Guzmán J, Pradillo JM, Moro MA, Lizasoain I (2017) Toll-like receptor 4 mediates hemorrhagic transformation after delayed tissue plasminogen activator administration in in situ thromboembolic stroke. Stroke 48(6):1695–1699. https://doi.org/10.1161/STROKEAHA.116.015956
García-Yébenes I, Sobrado M, Zarruk JG, Castellanos M, Pérez de la Ossa N, Dávalos A, Serena J, Lizasoain I, Moro MA (2011) A mouse model of hemorrhagic transformation by delayed tissue plasminogen activator administration after in situ thromboembolic stroke. Stroke 42(1):196–203. https://doi.org/10.1161/STROKEAHA.110.600452
Gauberti M, Obiang P, Guedin P, Balossier A, Gakuba C, Diependaele AS, Chazalviel L, Vivien D, Young AR, Agin V, Orset C (2012) Thrombotic stroke in the anesthetized monkey (Macaca mulatta): characterization by MRI—a pilot study. Cerebrovasc Dis 33(4):329–339. https://doi.org/10.1159/000335309
Ge WQ, Chen J, Pan H, Chen F, Zhou CY (2018) Analysis of risk factors increased hemorrhagic transformation after acute ischemic stroke. J Stroke Cerebrovasc Dis 27(12):3587–3590. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.08.028
Gerriets T, Li F, Silva MD, Meng X, Brevard M, Sotak CH, Fisher M (2003) The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats. J Neurosci Methods 122(2):201–211. https://doi.org/10.1016/s0165-0270(02)00322-9
Gerzanich V, Kwon MS, Woo SK, Ivanov A, Simard JM (2018) SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells. PLoS ONE 13(4):e0195526. https://doi.org/10.1371/journal.pone.0195526
Gidday JM, Gasche YG, Copin JC, Shah AR, Perez RS, Shapiro SD, Chan PH, Park TS (2005) Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol 289(2):H558-568. https://doi.org/10.1152/ajpheart.01275.2004
Gliem M, Mausberg AK, Lee JI, Simiantonakis I, van Rooijen N, Hartung HP, Jander S (2012) Macrophages prevent hemorrhagic infarct transformation in murine stroke models. Ann Neurol 71(6):743–752. https://doi.org/10.1002/ana.23529
Gong P, Li M, Zou C, Tian Q, Xu Z (2019) Tissue plasminogen activator causes brain microvascular endothelial cell injury after oxygen glucose deprivation by inhibiting sonic hedgehog signaling. Neurochem Res 44(2):441–449. https://doi.org/10.1007/s11064-018-2697-2
González-Conejero R, Fernández-Cadenas I, Iniesta JA, Marti-Fabregas J, Obach V, Alvarez-Sabín J, Vicente V, Corral J, Montaner J, Proyecto Ictus Research Group (2006) Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients. Stroke 37(9):2288–2293
Guinamard R, Sallé L, Simard C (2011) The non-selective monovalent cationic channels TRPM4 and TRPM5. Adv Exp Med Biol 704:147–171. https://doi.org/10.1007/978-94-007-0265-3_8
Guo ZN, Xu L, Hu Q, Matei N, Yang P, Tong LS, He Y, Guo Z, Tang J, Yang Y, Zhang JH (2016) Hyperbaric oxygen preconditioning attenuates hemorrhagic transformation through reactive oxygen species/thioredoxin-interacting protein/nod-like receptor protein 3 pathway in hyperglycemic middle cerebral artery occlusion rats. Crit Care Med 44(6):e403-411. https://doi.org/10.1097/CCM.0000000000001468
Haddad JJ, Land SC (2001) A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1alpha. FEBS Lett 505(2):269–274. https://doi.org/10.1016/s0014-5793(01)02833-2
Haddad M, Beray-Berthat V, Coqueran B, Palmier B, Szabo C, Plotkine M, Margaill I (2008) Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice. Eur J Pharmacol 588(1):52–57. https://doi.org/10.1016/j.ejphar.2008.04.013
Haddad M, Beray-Berthat V, Coqueran B, Plotkine M, Marchand-Leroux C, Margaill I (2013) Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice. Fundam Clin Pharmacol 27(4):393–401. https://doi.org/10.1111/j.1472-8206.2012.01036.x
Hafez S, Abdelsaid M, El-Shafey S, Johnson MH, Fagan SC, Ergul A (2016) Matrix metalloprotease 3 exacerbates hemorrhagic transformation and worsens functional outcomes in hyperglycemic stroke. Stroke 47(3):843–851. https://doi.org/10.1161/STROKEAHA.115.011258
Hafez S, Abdelsaid M, Fagan SC, Ergul A (2018) Peroxynitrite-induced tyrosine nitration contributes to matrix metalloprotease-3 activation: relevance to hyperglycemic ischemic brain injury and tissue plasminogen activator. Neurochem Res 43(2):259–266. https://doi.org/10.1007/s11064-017-2411-9
Henning EC, Latour LL, Hallenbeck JM, Warach S (2008) Reperfusion-associated hemorrhagic transformation in SHR rats: evidence of symptomatic parenchymal hematoma. Stroke 39(12):3405–3410. https://doi.org/10.1161/STROKEAHA.108.520304
Hernandez-Guillamon M, Garcia-Bonilla L, Solé M, Sosti V, Parés M, Campos M, Ortega-Aznar A, Domínguez C, Rubiera M, Ribó M, Quintana M, Molina CA, Alvarez-Sabín J, Rosell A, Unzeta M, Montaner J (2010) Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke. Stroke 41(7):1528–1535. https://doi.org/10.1161/STROKEAHA.110.584623
Hoffmann A, Stoffel MH, Nitzsche B, Lobsien D, Seeger J, Schneider H, Boltze J (2014) The ovine cerebral venous system: comparative anatomy, visualization, and implications for translational research. PLoS ONE 9(4):e92990. https://doi.org/10.1371/journal.pone.0092990
Hong JM, Lee JS, Song HJ, Jeong HS, Choi HA, Lee K (2014) Therapeutic hypothermia after recanalization in patients with acute ischemic stroke. Stroke 45(1):134–140. https://doi.org/10.1161/STROKEAHA.113.003143
Howells DW, Porritt MJ, Rewell SS, O’Collins V, Sena ES, van der Worp HB, Traystman RJ, Macleod MR (2010) Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J Cereb Blood Flow Metab 30(8):1412–1431. https://doi.org/10.1038/jcbfm.2010.66
Hu HJ, Song M (2017) Disrupted ionic homeostasis in ischemic stroke and new therapeutic targets. J Stroke Cerebrovasc Dis 26(12):2706–2719. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.09.011
Ikhsan M, Palumbo A, Rose D, Zille M, Boltze J (2019) Neuronal stem cell and drug interactions: a systematic review and meta-analysis: concise review. Stem Cells Transl Med 8(11):1202–1211. https://doi.org/10.1002/sctm.19-0020
Inzitari D, Giusti B, Nencini P, Gori AM, Nesi M, Palumbo V, Piccardi B, Armillis A, Pracucci G, Bono G, Bovi P, Consoli D, Guidotti M, Nucera A, Massaro F, Micieli G, Orlandi G, Perini F, Tassi R, Tola MR, Sessa M, Toni D, Abbate R, MAGIC Study Group (2013) MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death. Stroke 44(10):2901–2903. https://doi.org/10.1161/STROKEAHA.113.002274
Ishiguro M, Mishiro K, Fujiwara Y, Chen H, Izuta H, Tsuruma K, Shimazawa M, Yoshimura S, Satoh M, Iwama T, Hara H (2010) Phosphodiesterase-III inhibitor prevents hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPA. PLoS ONE 5(12):e15178. https://doi.org/10.1371/journal.pone.0015178
Jamieson JJ, Linville RM, Ding YY, Gerecht S, Searson PC (2019) Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D. Fluids Barriers CNS 16(1):15. https://doi.org/10.1186/s12987-019-0136-7
January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW (2019) 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation 140(2):e125–125e151
Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H, American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Peripheral Vascular Disease, Council on Clinical Cardiology (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44(3):870–947. https://doi.org/10.1161/STR.0b013e318284056a
Jean LeBlanc N, Menet R, Picard K, Parent G, Tremblay MÈ, ElAli A (2019) Canonical Wnt pathway maintains blood-brain barrier integrity upon ischemic stroke and its activation ameliorates tissue plasminogen activator therapy. Mol Neurobiol 56(9):6521–6538. https://doi.org/10.1007/s12035-019-1539-9
Jia W, Lu R, Martin TA, Jiang WG (2014) The role of claudin-5 in blood-brain barrier (BBB) and brain metastases (review). Mol Med Rep 9(3):779–785. https://doi.org/10.3892/mmr.2013.1875
Jiang RH, Zu QQ, Xu XQ, Wang B, Ding Y, Wang J, Liu S, Shi HB (2019) A canine model of hemorrhagic transformation using recombinant tissue plasminogen activator administration after acute ischemic stroke. Front Neurol 10:673. https://doi.org/10.3389/fneur.2019.00673
Jickling GC, Ander BP, Stamova B, Zhan X, Liu D, Rothstein L, Verro P, Khoury J, Jauch EC, Pancioli AM, Broderick JP, Sharp FR (2013) RNA in blood is altered prior to hemorrhagic transformation in ischemic stroke. Ann Neurol 74(2):232–240. https://doi.org/10.1002/ana.23883
Jickling GC, Liu D, Stamova B, Ander BP, Zhan X, Lu A, Sharp FR (2014) Hemorrhagic transformation after ischemic stroke in animals and humans. J Cereb Blood Flow Metab 34(2):185–199. https://doi.org/10.1038/jcbfm.2013.203
Jickling GC, Manolescu BN (2012) Breaking down barriers to identify hemorrhagic transformation in ischemic stroke. Neurology 79(16):1632–1633. https://doi.org/10.1212/WNL.0b013e31826e9b9d
Jin R, Yang G, Li G (2010) Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol Dis 38(3):376–385. https://doi.org/10.1016/j.nbd.2010.03.008
Jin R, Zhu X, Li G (2014) Embolic middle cerebral artery occlusion (MCAO) for ischemic stroke with homologous blood clots in rats. J Vis Exp 91:51956. https://doi.org/10.3791/51956
Kaiser EE, West FD (2020) Large animal ischemic stroke models: replicating human stroke pathophysiology. Neural Regen Res 15(8):1377–1387. https://doi.org/10.4103/1673-5374.274324
Kalinin MN, Khasanova DR, Ibatullin MM (2017) The hemorrhagic transformation index score: a prediction tool in middle cerebral artery ischemic stroke. BMC Neurol 17(1):177. https://doi.org/10.1186/s12883-017-0958-3
Kanazawa M, Igarashi H, Kawamura K, Takahashi T, Kakita A, Takahashi H, Nakada T, Nishizawa M, Shimohata T (2011) Inhibition of VEGF signaling pathway attenuates hemorrhage after tPA treatment. J Cereb Blood Flow Metab 31(6):1461–1474. https://doi.org/10.1038/jcbfm.2011.9
Kang J, Kim N, Park TH, Bang OY, Lee JS, Lee J, Han MK, Park SH, Gorelick PB, Bae HJ (2015) Early statin use in ischemic stroke patients treated with recanalization therapy: retrospective observational study. BMC Neurol 15:122. https://doi.org/10.1186/s12883-015-0367-4
Kassner A, Mandell DM, Mikulis DJ (2011) Measuring permeability in acute ischemic stroke. Neuroimaging Clin N Am 21(2):315–325, x–xi
Kawamura K, Takahashi T, Kanazawa M, Igarashi H, Nakada T, Nishizawa M, Shimohata T (2014) Effects of angiopoietin-1 on hemorrhagic transformation and cerebral edema after tissue plasminogen activator treatment for ischemic stroke in rats. PLoS ONE 9(6):e98639. https://doi.org/10.1371/journal.pone.0098639
Kazmierski R, Michalak S, Wencel-Warot A, Nowinski WL (2012) Serum tight-junction proteins predict hemorrhagic transformation in ischemic stroke patients. Neurology 79(16):1677–1685. https://doi.org/10.1212/WNL.0b013e31826e9a83
Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA, American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology aCoPVD (2014) Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45(7):2160–2236. https://doi.org/10.1161/STR.0000000000000024
Khatri R, McKinney AM, Swenson B, Janardhan V (2012) Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology 79(13 Suppl 1):S52-57. https://doi.org/10.1212/WNL.0b013e3182697e70
Kikuchi K, Miura N, Kawahara KI, Murai Y, Morioka M, Lapchak PA, Tanaka E (2013) Edaravone (Radicut), a free radical scavenger, is a potentially useful addition to thrombolytic therapy in patients with acute ischemic stroke. Biomed Rep 1(1):7–12. https://doi.org/10.3892/br.2012.7
Kikuchi K, Setoyama K, Tanaka E, Otsuka S, Terashi T, Nakanishi K, Takada S, Sakakima H, Ampawong S, Kawahara KI, Nagasato T, Hosokawa K, Harada Y, Yamamoto M, Kamikokuryo C, Kiyama R, Morioka M, Ito T, Maruyama I, Tancharoen S (2018) Uric acid enhances alteplase-mediated thrombolysis as an antioxidant. Sci Rep 8(1):15844. https://doi.org/10.1038/s41598-018-34220-1
Kilic E, Bähr M, Hermann DM (2001) Effects of recombinant tissue plasminogen activator after intraluminal thread occlusion in mice: role of hemodynamic alterations. Stroke 32(11):2641–2647. https://doi.org/10.1161/hs1101.097381
Kim BJ, Lee SH, Ryu WS, Kang BS, Kim CK, Yoon BW (2009) Low level of low-density lipoprotein cholesterol increases hemorrhagic transformation in large artery atherothrombosis but not in cardioembolism. Stroke 40(5):1627–1632. https://doi.org/10.1161/STROKEAHA.108.539643
Kim EM, Hwang O (2011) Role of matrix metalloproteinase-3 in neurodegeneration. J Neurochem 116(1):22–32. https://doi.org/10.1111/j.1471-4159.2010.07082.x
Kim TJ, Park HK, Kim JM, Lee JS, Park SH, Jeong HB, Park KY, Rha JH, Yoon BW, Ko SB (2019) Blood pressure variability and hemorrhagic transformation in patients with successful recanalization after endovascular recanalization therapy: a retrospective observational study. Ann Neurol 85(4):574–581. https://doi.org/10.1002/ana.25434
Kimberly WT, Battey TW, Pham L, Wu O, Yoo AJ, Furie KL, Singhal AB, Elm JJ, Stern BJ, Sheth KN (2014) Glyburide is associated with attenuated vasogenic edema in stroke patients. Neurocrit Care 20(2):193–201. https://doi.org/10.1007/s12028-013-9917-z
Klingbeil KD, Koch S, Dave KR (2017) Potential link between post-acute ischemic stroke exposure to hypoglycemia and hemorrhagic transformation. Int J Stroke. https://doi.org/10.1177/1747493017743797
Kraskiewicz H, FitzGerald U (2011) Partial XBP1 knockdown does not affect viability of oligodendrocyte precursor cells exposed to new models of hypoxia and ischemia in vitro. J Neurosci Res 89(5):661–673. https://doi.org/10.1002/jnr.22583
Kuhn DM, Sakowski SA, Sadidi M, Geddes TJ (2004) Nitrotyrosine as a marker for peroxynitrite-induced neurotoxicity: the beginning or the end of the end of dopamine neurons. J Neurochem 89(3):529–536. https://doi.org/10.1111/j.1471-4159.2004.02346.x
Kunte H, Busch MA, Trostdorf K, Vollnberg B, Harms L, Mehta RI, Castellani RJ, Mandava P, Kent TA, Simard JM (2012) Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas. Ann Neurol 72(5):799–806. https://doi.org/10.1002/ana.23680
Kuroki T, Tanaka R, Shimada Y, Yamashiro K, Ueno Y, Shimura H, Urabe T, Hattori N (2016) Exendin-4 inhibits matrix metalloproteinase-9 activation and reduces infarct growth after focal cerebral ischemia in hyperglycemic mice. Stroke 47(5):1328–1335. https://doi.org/10.1161/STROKEAHA.116.012934
Kwon I, Kim EH, del Zoppo GJ, Heo JH (2009) Ultrastructural and temporal changes of the microvascular basement membrane and astrocyte interface following focal cerebral ischemia. J Neurosci Res 87(3):668–676. https://doi.org/10.1002/jnr.21877
Lafrenaye AD, Simard JM (2019) Bursting at the seams: molecular mechanisms mediating astrocyte swelling. Int J Mol Sci. https://doi.org/10.3390/ijms20020330
Lampl Y, Boaz M, Gilad R, Lorberboym M, Dabby R, Rapoport A, Anca-Hershkowitz M, Sadeh M (2007) Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 69(14):1404–1410. https://doi.org/10.1212/01.wnl.0000277487.04281.db
Lan X, Han X, Li Q, Yang QW, Wang J (2017) Modulators of microglial activation and polarization after intracerebral haemorrhage. Nat Rev Neurol 13(7):420–433. https://doi.org/10.1038/nrneurol.2017.69
Lan X, Han X, Liu X, Wang J (2019) Inflammatory responses after intracerebral hemorrhage: from cellular function to therapeutic targets. J Cereb Blood Flow Metab 39(1):184–186. https://doi.org/10.1177/0271678X18805675
Lansberg MG, O’Donnell MJ, Khatri P, Lang ES, Nguyen-Huynh MN, Schwartz NE, Sonnenberg FA, Schulman S, Vandvik PO, Spencer FA, Alonso-Coello P, Guyatt GH, Akl EA (2012) Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e601S-e636S. https://doi.org/10.1378/chest.11-2302
Lapchak PA (2007) Tumor necrosis factor-alpha is involved in thrombolytic-induced hemorrhage following embolic strokes in rabbits. Brain Res 1167:123–128. https://doi.org/10.1016/j.brainres.2007.06.072
Lapchak PA, Araujo DM, Song D, Zivin JA (2002) The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke. Stroke 33(1):147–152. https://doi.org/10.1161/hs0102.100530
Lee RH, Bergmeier W (2016) Platelet immunoreceptor tyrosine-based activation motif (ITAM) and hemITAM signaling and vascular integrity in inflammation and development. J Thromb Haemost 14(4):645–654. https://doi.org/10.1111/jth.13250
Lee XR, Xiang GL (2018) Effects of edaravone, the free radical scavenger, on outcomes in acute cerebral infarction patients treated with ultra-early thrombolysis of recombinant tissue plasminogen activator. Clin Neurol Neurosurg 167:157–161. https://doi.org/10.1016/j.clineuro.2018.02.026
Lee YB, Yoon W, Lee YY, Kim SK, Baek BH, Kim JT, Park MS (2019) Predictors and impact of hemorrhagic transformations after endovascular thrombectomy in patients with acute large vessel occlusions. J Neurointerv Surg 11(5):469–473. https://doi.org/10.1136/neurintsurg-2018-014080
Lei C, Wu B, Liu M, Chen Y (2014) Asymptomatic hemorrhagic transformation after acute ischemic stroke: is it clinically innocuous. J Stroke Cerebrovasc Dis 23(10):2767–2772. https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.06.024
Leigh R, Jen SS, Hillis AE, Krakauer JW, Barker PB, STIR and VISTA Imaging Investigators (2014) Pretreatment blood-brain barrier damage and post-treatment intracranial hemorrhage in patients receiving intravenous tissue-type plasminogen activator. Stroke 45(7):2030–2035. https://doi.org/10.1161/STROKEAHA.114.005249
Li M, Chen S, Shi X, Lyu C, Zhang Y, Tan M, Wang C, Zang N, Liu X, Hu Y, Shen J, Zhou L, Gu Y (2018) Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke. J Neuroinflamm 15(1):237. https://doi.org/10.1186/s12974-018-1267-5
Li M, Zhang Z, Sun W, Koehler RC, Huang J (2011) 17β-estradiol attenuates breakdown of blood-brain barrier and hemorrhagic transformation induced by tissue plasminogen activator in cerebral ischemia. Neurobiol Dis 44(3):277–283. https://doi.org/10.1016/j.nbd.2011.07.004
Li Q, Han X, Lan X, Hong X, Li Q, Gao Y, Luo T, Yang Q, Koehler RC, Zhai Y, Zhou J, Wang J (2017) Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia. Neurobiol Dis 108:173–182. https://doi.org/10.1016/j.nbd.2017.08.011
Li W, Lin L, Zhang M, Wu Y, Liu C, Li X, Huang S, Liang C, Wang Y, Chen J, Feng W (2016) Safety and preliminary efficacy of early tirofiban treatment after alteplase in acute ischemic stroke patients. Stroke 47(10):2649–2651. https://doi.org/10.1161/STROKEAHA.116.014413
Li YN, Pan R, Qin XJ, Yang WL, Qi Z, Liu W, Liu KJ (2014) Ischemic neurons activate astrocytes to disrupt endothelial barrier via increasing VEGF expression. J Neurochem 129(1):120–129. https://doi.org/10.1111/jnc.12611
Liang AC, Mandeville ET, Maki T, Shindo A, Som AT, Egawa N, Itoh K, Chuang TT, McNeish JD, Holder JC, Lok J, Lo EH, Arai K (2016) Effects of aging on neural stem/progenitor cells and oligodendrocyte precursor cells after focal cerebral ischemia in spontaneously hypertensive rats. Cell Transplant 25(4):705–714. https://doi.org/10.3727/096368916X690557
Liang J, Qi Z, Liu W, Wang P, Shi W, Dong W, Ji X, Luo Y, Liu KJ (2015) Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia. Stroke 46(5):1344–1351. https://doi.org/10.1161/STROKEAHA.114.008599
Lin K, Zink WE, Tsiouris AJ, John M, Tekchandani L, Sanelli PC (2012) Risk assessment of hemorrhagic transformation of acute middle cerebral artery stroke using multimodal CT. J Neuroimaging 22(2):160–166. https://doi.org/10.1111/j.1552-6569.2010.00562.x
Liu J, Jin X, Liu KJ, Liu W (2012) Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J Neurosci 32(9):3044–3057. https://doi.org/10.1523/JNEUROSCI.6409-11.2012
Liu K, Yan S, Zhang S, Guo Y, Lou M (2016) Systolic blood pressure variability is associated with severe hemorrhagic transformation in the early stage after thrombolysis. Transl Stroke Res 7(3):186–191. https://doi.org/10.1007/s12975-016-0458-6
Liu L, Wu B, Zhao J, Cao Y, Dedhia N, Caplan LR, Wang Q (2017) Computed tomography perfusion alberta stroke program early computed tomography score is associated with hemorrhagic transformation after acute cardioembolic stroke. Front Neurol 8:591. https://doi.org/10.3389/fneur.2017.00591
Liu NW, Ke CC, Zhao Y, Chen YA, Chan KC, Tan DT, Lee JS, Chen YY, Hsu TW, Hsieh YJ, Chang CW, Yang BH, Huang WS, Liu RS (2017) Evolutional characterization of photochemically induced stroke in rats: a multimodality imaging and molecular biological study. Transl Stroke Res 8(3):244–256. https://doi.org/10.1007/s12975-016-0512-4
Liu S, Zhen G, Meloni BP, Campbell K, Winn HR (2009) Rodent stroke model guidelines for preclinical stroke trials (1st edition). J Exp Stroke Transl Med 2(2):2–27
Lou M, Safdar A, Mehdiratta M, Kumar S, Schlaug G, Caplan L, Searls D, Selim M (2008) The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology 71(18):1417–1423. https://doi.org/10.1212/01.wnl.0000330297.58334.dd
Lu A, Clark JF, Broderick JP, Pyne-Geithman GJ, Wagner KR, Khatri P, Tomsick T, Sharp FR (2009) Mechanical reperfusion is associated with post-ischemic hemorrhage in rat brain. Exp Neurol 216(2):407–412. https://doi.org/10.1016/j.expneurol.2008.12.020
Lu A, Suofu Y, Guan F, Broderick JP, Wagner KR, Clark JF (2013) Matrix metalloproteinase-2 deletions protect against hemorrhagic transformation after 1 h of cerebral ischemia and 23 h of reperfusion. Neurosci 253:361–367. https://doi.org/10.1016/j.neuroscience.2013.08.068
Lu D, Liu Y, Mai H, Zang J, Shen L, Zhang Y, Xu A (2018) Rosuvastatin reduces neuroinflammation in the hemorrhagic transformation after rt-PA treatment in a mouse model of experimental stroke. Front Cell Neurosci 12:225. https://doi.org/10.3389/fncel.2018.00225
Luo H, Wei L, Lu L, Kang L, Cao Y, Yang X, Bai X, Fan W, Zhao BQ (2019) Transfusion of resting platelets reduces brain hemorrhage after intracerebral hemorrhage and tPA-induced hemorrhage after cerebral ischemia. Front Neurosci 13:338. https://doi.org/10.3389/fnins.2019.00338
Lv J, Hu W, Yang Z, Li T, Jiang S, Ma Z, Chen F, Yang Y (2018) Focusing on claudin-5: a promising candidate in the regulation of BBB to treat ischemic stroke. Prog Neurobiol 161:79–96. https://doi.org/10.1016/j.pneurobio.2017.12.001
Lyden P, Pryor KE, Coffey CS, Cudkowicz M, Conwit R, Jadhav A, Sawyer RN Jr, Claassen J, Adeoye O, Song S, Hannon P, Rost NS, Hinduja A, Torbey M, Lee JM, Benesch C, Rippee M, Rymer M, Froehler MT, Clarke Haley E, Johnson M, Yankey J, Magee K, Qidwai J, Levy H, Mark Haacke E, Fawaz M, Davis TP, Toga AW, Griffin JH, Zlokovic BV, NeuroNEXT Clinical Trials Network NN104 Investigators (2019) Final results of the RHAPSODY trial: a multi-center, phase 2 trial using a continual reassessment method to determine the safety and tolerability of 3K3A-APC, a recombinant variant of human activated protein C, in combination with tissue plasminogen activator, mechanical thrombectomy or both in moderate to severe acute ischemic stroke. Ann Neurol 85(1):125–136. https://doi.org/10.1002/ana.25383
Ma LL, Song L, Yu XD, Yu TX, Liang H, Qiu JX (2017) The clinical study on the treatment for acute cerebral infarction by intra-arterial thrombolysis combined with mild hypothermia. Eur Rev Med Pharmacol Sci 21(8):1999–2006
Ma Y, Li L, Kong L, Zhu Z, Zhang W, Song J, Chang J, Du G (2018) Pinocembrin protects blood-brain barrier function and expands the therapeutic time window for tissue-type plasminogen activator treatment in a rat thromboembolic stroke model. Biomed Res Int 2018:8943210. https://doi.org/10.1155/2018/8943210
Machado LS, Sazonova IY, Kozak A, Wiley DC, El-Remessy AB, Ergul A, Hess DC, Waller JL, Fagan SC (2009) Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential. Stroke 40(9):3028–3033. https://doi.org/10.1161/STROKEAHA.109.556852
Machida T, Takata F, Matsumoto J, Takenoshita H, Kimura I, Yamauchi A, Dohgu S, Kataoka Y (2015) Brain pericytes are the most thrombin-sensitive matrix metalloproteinase-9-releasing cell type constituting the blood-brain barrier in vitro. Neurosci Lett 599:109–114. https://doi.org/10.1016/j.neulet.2015.05.028
Maeda M, Furuichi Y, Noto T, Matsuoka N, Mutoh S, Yoneda Y (2009) Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model. Brain Res 1254:99–108. https://doi.org/10.1016/j.brainres.2008.11.080
Maestrini I, Strbian D, Gautier S, Haapaniemi E, Moulin S, Sairanen T, Dequatre-Ponchelle N, Sibolt G, Cordonnier C, Melkas S, Leys D, Tatlisumak T, Bordet R (2015) Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes. Neurology 85(16):1408–1416. https://doi.org/10.1212/WNL.0000000000002029
Maida C, Tuttolomondo A, Di Raimondo D, Daidone M, Pinto A (2017) Management of blood pressure and heart rate in patients with acute stroke. Curr Pharm Des 23(31):4583–4597. https://doi.org/10.2174/1381612823666170714162455
Mao L, Li P, Zhu W, Cai W, Liu Z, Wang Y, Luo W, Stetler RA, Leak RK, Yu W, Gao Y, Chen J, Chen G, Hu X (2017) Regulatory T cells ameliorate tissue plasminogen activator-induced brain haemorrhage after stroke. Brain 140(7):1914–1931. https://doi.org/10.1093/brain/awx111
Marcos-Contreras OA, Martinez de Lizarrondo S, Bardou I, Orset C, Pruvost M, Anfray A, Frigout Y, Hommet Y, Lebouvier L, Montaner J, Vivien D, Gauberti M (2016) Hyperfibrinolysis increases blood-brain barrier permeability by a plasmin- and bradykinin-dependent mechanism. Blood 128(20):2423–2434. https://doi.org/10.1182/blood-2016-03-705384
Marsh EB, Llinas RH, Hillis AE, Gottesman RF (2013) Hemorrhagic transformation in patients with acute ischaemic stroke and an indication for anticoagulation. Eur J Neurol 20(6):962–967. https://doi.org/10.1111/ene.12126
Marsh EB, Llinas RH, Schneider AL, Hillis AE, Lawrence E, Dziedzic P, Gottesman RF (2016) Predicting hemorrhagic transformation of acute ischemic stroke: prospective validation of the HeRS score. Medicine (Baltimore) 95(2):e2430. https://doi.org/10.1097/MD.0000000000002430
Masjuan J, DeFelipe A (2017) Secondary prevention in non-valvular atrial fibrillation patients: a practical approach with edoxaban. Int J Neurosci 127(8):716–725. https://doi.org/10.1080/00207454.2016.1232256
Mathews MT, Berk BC (2008) PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2. Arterioscler Thromb Vasc Biol 28(4):711–717. https://doi.org/10.1161/ATVBAHA.107.156406
Matsuo Y, Si M, Ninomiya M, Fujimoto M (2001) Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats. Stroke 32(9):2143–2148. https://doi.org/10.1161/hs0901.94259
Mayzel-Oreg O, Omae T, Kazemi M, Li F, Fisher M, Cohen Y, Sotak CH (2004) Microsphere-induced embolic stroke: an MRI study. Magn Reson Med 51(6):1232–1238. https://doi.org/10.1002/mrm.20100
Mazya M, Egido JA, Ford GA, Lees KR, Mikulik R, Toni D, Wahlgren N, Ahmed N, Investigators SITS (2012) Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke 43(6):1524–1531. https://doi.org/10.1161/STROKEAHA.111.644815
McCarron MO, Nicoll JA (2004) Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage. Lancet Neurol 3(8):484–492. https://doi.org/10.1016/S1474-4422(04)00825-7
Menon BK, Saver JL, Prabhakaran S, Reeves M, Liang L, Olson DM, Peterson ED, Hernandez AF, Fonarow GC, Schwamm LH, Smith EE (2012) Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke 43(9):2293–2299. https://doi.org/10.1161/STROKEAHA.112.660415
Montaner J, Bustamante A, García-Matas S, Martínez-Zabaleta M, Jiménez C, de la Torre J, Rubio FR, Segura T, Masjuán J, Cánovas D, Freijo M, Delgado-Mederos R, Tejada J, Lago A, Bravo Y, Corbeto N, Giralt D, Vives-Pastor B, de Arce A, Moniche F, Delgado P, Ribó M, STARS Investigators (2016) Combination of thrombolysis and statins in acute stroke is safe: results of the STARS randomized trial (stroke treatment with acute reperfusion and simvastatin). Stroke 47(11):2870–2873. https://doi.org/10.1161/STROKEAHA.116.014600
Montaner J, Molina CA, Monasterio J, Abilleira S, Arenillas JF, Ribó M, Quintana M, Alvarez-Sabín J (2003) Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107(4):598–603. https://doi.org/10.1161/01.cir.0000046451.38849.90
Morris DC, Zhang L, Zhang ZG, Lu M, Berens KL, Brown PM, Chopp M (2001) Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke. Stroke 32(11):2635–2640. https://doi.org/10.1161/hs1101.097390
Moshal KS, Singh M, Sen U, Rosenberger DS, Henderson B, Tyagi N, Zhang H, Tyagi SC (2006) Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC. Am J Physiol Heart Circ Physiol 291(6):H2825-2835. https://doi.org/10.1152/ajpheart.00377.2006
Moskowitz MA, Lo EH, Iadecola C (2010) The science of stroke: mechanisms in search of treatments. Neuron 67(2):181–198. https://doi.org/10.1016/j.neuron.2010.07.002
Mracsko E, Liesz A, Stojanovic A, Lou WP, Osswald M, Zhou W, Karcher S, Winkler F, Martin-Villalba A, Cerwenka A, Veltkamp R (2014) Antigen dependently activated cluster of differentiation 8-positive T cells cause perforin-mediated neurotoxicity in experimental stroke. J Neurosci 34(50):16784–16795. https://doi.org/10.1523/JNEUROSCI.1867-14.2014
Murata Y, Rosell A, Scannevin RH, Rhodes KJ, Wang X, Lo EH (2008) Extension of the thrombolytic time window with minocycline in experimental stroke. Stroke 39(12):3372–3377. https://doi.org/10.1161/STROKEAHA.108.514026
Nagaraja N, Tasneem N, Shaban A, Dandapat S, Ahmed U, Policeni B, Olalde H, Shim H, Samaniego EA, Pieper C, Ortega-Gutierrez S, Leira EC, Adams HP Jr (2018) Cerebral microbleeds are an independent predictor of hemorrhagic transformation following intravenous alteplase administration in acute ischemic stroke. J Stroke Cerebrovasc Dis 27(5):1403–1411. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.12.044
Nardi K, Leys D, Eusebi P, Cordonnier C, Gautier S, Hénon H, Bordet R (2011) Influence of lipid profiles on the risk of hemorrhagic transformation after ischemic stroke: systematic review. Cerebrovasc Dis Extra 1(1):130–141. https://doi.org/10.1159/000335014
Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, Vivien D, Buisson A (2001) The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 7(1):59–64. https://doi.org/10.1038/83358
Nighoghossian N, Hermier M, Berthezène Y, Wiart M, Derex L, Honnorat J, Trouillas P, Turjman F, Froment JC (2001) Early diagnosis of hemorrhagic transformation: diffusion/perfusion-weighted MRI versus CT scan. Cerebrovasc Dis 11(3):151–156. https://doi.org/10.1159/000047631
Nilius B, Prenen J, Tang J, Wang C, Owsianik G, Janssens A, Voets T, Zhu MX (2005) Regulation of the Ca2+ sensitivity of the nonselective cation channel TRPM4. J Biol Chem 280(8):6423–6433. https://doi.org/10.1074/jbc.M411089200
O’Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW (2006) 1,026 experimental treatments in acute stroke. Ann Neurol 59(3):467–477. https://doi.org/10.1002/ana.20741
Okamura K, Tsubokawa T, Johshita H, Miyazaki H, Shiokawa Y (2014) Edaravone, a free radical scavenger, attenuates cerebral infarction and hemorrhagic infarction in rats with hyperglycemia. Neurol Res 36(1):65–69. https://doi.org/10.1179/1743132813Y.0000000259
Okubo S, Igarashi H, Kanamatsu T, Hasegawa D, Orima H, Katayama Y (2007) FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model. Brain Res 1143:221–227. https://doi.org/10.1016/j.brainres.2007.01.050
Orbe J, Alexandru N, Roncal C, Belzunce M, Bibiot P, Rodriguez JA, Meijers JC, Georgescu A, Paramo JA (2015) Lack of TAFI increases brain damage and microparticle generation after thrombolytic therapy in ischemic stroke. Thromb Res 136(2):445–450. https://doi.org/10.1016/j.thromres.2015.06.010
Orset C, Macrez R, Young AR, Panthou D, Angles-Cano E, Maubert E, Agin V, Vivien D (2007) Mouse model of in situ thromboembolic stroke and reperfusion. Stroke 38(10):2771–2778. https://doi.org/10.1161/STROKEAHA.107.487520
Paciaroni M, Agnelli G, Caso V, Corea F, Ageno W, Alberti A, Lanari A, Micheli S, Bertolani L, Venti M, Palmerini F, Billeci AM, Comi G, Previdi P, Silvestrelli G (2009) Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. Cerebrovasc Dis 28(2):119–123. https://doi.org/10.1159/000223436
Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A, Caso V, Micheli S, Bertolani L, Venti M, Palmerini F, Biagini S, Comi G, Previdi P, Silvestrelli G (2008) Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke 39(8):2249–2256. https://doi.org/10.1161/STROKEAHA.107.510321
Paciaroni M, Bandini F, Agnelli G, Tsivgoulis G, Yaghi S, Furie KL, Tadi P, Becattini C, Zedde M, Abdul-Rahim AH, Lees KR, Alberti A, Venti M, Acciarresi M, D’Amore C, Mosconi MG, Cimini LA, Altavilla R, Volpi G, Bovi P, Carletti M, Rigatelli A, Cappellari M, Putaala J, Tomppo L, Tatlisumak T, Marcheselli S, Pezzini A, Poli L, Padovani A, Masotti L, Vannucchi V, Sohn SI, Lorenzini G, Tassi R, Guideri F, Acampa M, Martini G, Ntaios G, Athanasakis G, Makaritsis K, Karagkiozi E, Vadikolias K, Liantinioti C, Chondrogianni M, Mumoli N, Consoli D, Galati F, Sacco S, Carolei A, Tiseo C, Corea F, Ageno W, Bellesini M, Colombo G, Silvestrelli G, Ciccone A, Lanari A, Scoditti U, Denti L, Mancuso M, Maccarrone M, Ulivi L, Orlandi G, Giannini N, Gialdini G, Tassinari T, De Lodovici ML, Bono G, Rueckert C, Baldi A, D’Anna S, Toni D, Letteri F, Giuntini M, Lotti EM, Flomin Y, Pieroni A, Kargiotis O, Karapanayiotides T, Monaco S, Maimone Baronello M, Csiba L, Szabó L, Chiti A, Giorli E, Del Sette M, Imberti D, Zabzuni D, Doronin B, Volodina V, Michel P, Vanacker P, Barlinn K, Pallesen LP, Barlinn J, Deleu D, Melikyan G, Ibrahim F, Akhtar N, Gourbali V, Caso V (2018) Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: time to initiation of oral anticoagulant therapy and outcomes. J Am Heart Assoc 7(22):e010133. https://doi.org/10.1161/JAHA.118.010133
Page S, Munsell A, Al-Ahmad AJ (2016) Cerebral hypoxia/ischemia selectively disrupts tight junctions complexes in stem cell-derived human brain microvascular endothelial cells. Fluids Barriers CNS 13(1):16. https://doi.org/10.1186/s12987-016-0042-1
Park CH, Shin TK, Lee HY, Kim SJ, Lee WS (2011) Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice. Korean J Physiol Pharmacol 15(2):115–122. https://doi.org/10.4196/kjpp.2011.15.2.115
Park JM, Kang K, Cho YJ, Hong KS, Lee KB, Park TH, Lee SJ, Ko Y, Han MK, Lee J, Cha JK, Kim DH, Kim DE, Kim JT, Choi JC, Yu KH, Lee BC, Lee JS, Lee J, Gorelick PB, Bae HJ, CRCS-5 Investigators (2016) Comparative effectiveness of prestroke aspirin on stroke severity and outcome. Ann Neurol 79(4):560–568. https://doi.org/10.1002/ana.24602
Park JY, Hwang EM, Yarishkin O, Seo JH, Kim E, Yoo J, Yi GS, Kim DG, Park N, Ha CM, La JH, Kang D, Han J, Oh U, Hong SG (2008) TRPM4b channel suppresses store-operated Ca2+ entry by a novel protein-protein interaction with the TRPC3 channel. Biochem Biophys Res Commun 368(3):677–683. https://doi.org/10.1016/j.bbrc.2008.01.153
Pehar M, Vargas MR, Cassina P, Barbeito AG, Beckman JS, Barbeito L (2005) Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis. Neurodegener Dis 2(3–4):139–146. https://doi.org/10.1159/000089619
Pellegrini-Giampietro DE, Cherici G, Alesiani M, Carlà V, Moroni F (1988) Excitatory amino acid release from rat hippocampal slices as a consequence of free-radical formation. J Neurochem 51(6):1960–1963. https://doi.org/10.1111/j.1471-4159.1988.tb01187.x
Polavarapu R, Gongora MC, Yi H, Ranganthan S, Lawrence DA, Strickland D, Yepes M (2007) Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit. Blood 109(8):3270–3278. https://doi.org/10.1182/blood-2006-08-043125
Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC, Johnston KC, Johnston SC, Khalessi AA, Kidwell CS, Meschia JF, Ovbiagele B, Yavagal DR, Council AHAS (2015) 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 46(10):3020–3035. https://doi.org/10.1161/STR.0000000000000074
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL, Council AHAS (2018) 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 49(3):e46-46e110. https://doi.org/10.1161/STR.0000000000000158
Prodan CI, Stoner JA, Cowan LD, Dale GL (2010) Lower coated-platelet levels are associated with early hemorrhagic transformation in patients with non-lacunar brain infarction. J Thromb Haemost 8(6):1185–1190. https://doi.org/10.1111/j.1538-7836.2010.03851.x
Puetz V, Dzialowski I, Hill MD, Subramaniam S, Sylaja PN, Krol A, O’Reilly C, Hudon ME, Hu WY, Coutts SB, Barber PA, Watson T, Roy J, Demchuk AM, Calgary CTA Study Group (2008) Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score. Int J Stroke 3(4):230–236
Puetz V, Sylaja PN, Hill MD, Coutts SB, Dzialowski I, Becker U, Gahn G, von Kummer R, Demchuk AM (2009) CT angiography source images predict final infarct extent in patients with basilar artery occlusion. AJNR Am J Neuroradiol 30(10):1877–1883. https://doi.org/10.3174/ajnr.A1723
Qian T, Maguire SE, Canfield SG, Bao X, Olson WR, Shusta EV, Palecek SP (2017) Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells. Sci Adv 3(11):e1701679. https://doi.org/10.1126/sciadv.1701679
Qiu J, Xu J, Zheng Y, Wei Y, Zhu X, Lo EH, Moskowitz MA, Sims JR (2010) High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia. Stroke 41(9):2077–2082. https://doi.org/10.1161/STROKEAHA.110.590463
Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, Moy CS, Silbergleit R, Steiner T, Suarez JI, Toyoda K, Wang Y, Yamamoto H, Yoon BW, ATACH-2 Trial Investigators and the Neurological Emergency Treatment Trials Network (2016) Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med 375(11):1033–1043. https://doi.org/10.1056/NEJMoa1603460
Redzic ZB, Rabie T, Sutherland BA, Buchan AM (2015) Differential effects of paracrine factors on the survival of cells of the neurovascular unit during oxygen glucose deprivation. Int J Stroke 10(3):407–414. https://doi.org/10.1111/ijs.12197
Ren H, Han R, Chen X, Liu X, Wan J, Wang L, Yang X, Wang J (2020) Potential therapeutic targets for intracerebral hemorrhage-associated inflammation: an update. J Cereb Blood Flow Metab 40(9):1752–1768. https://doi.org/10.1177/0271678X20923551
Rha JH, Saver JL (2007) The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 38(3):967–973. https://doi.org/10.1161/01.STR.0000258112.14918.24
Ribo M, Montaner J, Molina CA, Arenillas JF, Santamarina E, Quintana M, Alvarez-Sabín J (2004) Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator. Stroke 35(9):2123–2127. https://doi.org/10.1161/01.STR.0000137608.73660.4c
Ritzel RM, Lai YJ, Crapser JD, Patel AR, Schrecengost A, Grenier JM, Mancini NS, Patrizz A, Jellison ER, Morales-Scheihing D, Venna VR, Kofler JK, Liu F, Verma R, McCullough LD (2018) Aging alters the immunological response to ischemic stroke. Acta Neuropathol 136(1):89–110. https://doi.org/10.1007/s00401-018-1859-2
Rodríguez-Yáñez M, Castillo J (2008) Role of inflammatory markers in brain ischemia. Curr Opin Neurol 21(3):353–357. https://doi.org/10.1097/WCO.0b013e3282ffafbf
Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY (2013) The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol 62(23):2199–2204. https://doi.org/10.1016/j.jacc.2013.08.1623
Romanos E, Planas AM, Amaro S, Chamorro A (2007) Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke. J Cereb Blood Flow Metab 27(1):14–20. https://doi.org/10.1038/sj.jcbfm.9600312
Ronaldson PT, Davis TP (2012) Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke. Curr Pharm Des 18(25):3624–3644. https://doi.org/10.2174/138161212802002625
Roussel BD, Mysiorek C, Rouhiainen A, Jullienne A, Parcq J, Hommet Y, Culot M, Berezowski V, Cecchelli R, Rauvala H, Vivien D, Ali C (2011) HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activator. J Cell Sci 124(Pt 12):2070–2076. https://doi.org/10.1242/jcs.084392
Salas-Perdomo A, Miró-Mur F, Urra X, Justicia C, Gallizioli M, Zhao Y, Brait VH, Laredo C, Tudela R, Hidalgo A, Chamorro Á, Planas AM (2018) T cells prevent hemorrhagic transformation in ischemic stroke by P-selectin binding. Arterioscler Thromb Vasc Biol 38(8):1761–1771. https://doi.org/10.1161/ATVBAHA.118.311284
Sandercock PA, Counsell C, Kane EJ (2015) Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD000024.pub4
Saposnik G, Fang J, Kapral MK, Tu JV, Mamdani M, Austin P, Johnston SC, Investigators of the Registry of the Canadian Stroke Network (RCSN), Stroke Outcomes Research Canada (SORCan) Working Group (2012) The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke. Stroke 43(5):1315–1322
Saposnik G, Guzik AK, Reeves M, Ovbiagele B, Johnston SC (2013) Stroke prognostication using age and NIH stroke scale: SPAN-100. Neurology 80(1):21–28. https://doi.org/10.1212/WNL.0b013e31827b1ace
Scalzo F, Alger JR, Hu X, Saver JL, Dani KA, Muir KW, Demchuk AM, Coutts SB, Luby M, Warach S, Liebeskind DS, STIR, VISTA Imaging Investigators (2013) Multi-center prediction of hemorrhagic transformation in acute ischemic stroke using permeability imaging features. Magn Reson Imaging 31(6):961–969. https://doi.org/10.1016/j.mri.2013.03.013
Schwamm LH, Fonarow GC, Reeves MJ, Pan W, Frankel MR, Smith EE, Ellrodt G, Cannon CP, Liang L, Peterson E, Labresh KA (2009) Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation 119(1):107–115. https://doi.org/10.1161/CIRCULATIONAHA.108.783688
Schwamm LH, Rosenthal ES, Swap CJ, Rosand J, Rordorf G, Buonanno FS, Vangel MG, Koroshetz WJ, Lev MH (2005) Hypoattenuation on CT angiographic source images predicts risk of intracerebral hemorrhage and outcome after intra-arterial reperfusion therapy. AJNR Am J Neuroradiol 26(7):1798–1803
Selim M, Fink JN, Kumar S, Caplan LR, Horkan C, Chen Y, Linfante I, Schlaug G (2002) Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke 33(8):2047–2052. https://doi.org/10.1161/01.str.0000023577.65990.4e
Semenza GL (2000) Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1. J Clin Invest 106(7):809–812. https://doi.org/10.1172/JCI11223
Shah FA, Kury LA, Li T, Zeb A, Koh PO, Liu F, Zhou Q, Hussain I, Khan AU, Jiang Y, Li S (2019) Polydatin attenuates neuronal loss via reducing neuroinflammation and oxidative stress in rat MCAO models. Front Pharmacol 10:663. https://doi.org/10.3389/fphar.2019.00663
Sharp FR, Bernaudin M (2004) HIF1 and oxygen sensing in the brain. Nat Rev Neurosci 5(6):437–448. https://doi.org/10.1038/nrn1408
Sheth KN, Simard JM, Elm J, Kronenberg G, Kunte H, Kimberly WT (2016) Human data supporting glyburide in ischemic stroke. Acta Neurochir Suppl 121:13–18. https://doi.org/10.1007/978-3-319-18497-5_3
Simard JM, Geng Z, Silver FL, Sheth KN, Kimberly WT, Stern BJ, Colucci M, Gerzanich V (2012) Does inhibiting Sur1 complement rt-PA in cerebral ischemia. Ann N Y Acad Sci 1268:95–107. https://doi.org/10.1111/j.1749-6632.2012.06705.x
Simard JM, Kahle KT, Gerzanich V (2010) Molecular mechanisms of microvascular failure in central nervous system injury–synergistic roles of NKCC1 and SUR1/TRPM4. J Neurosurg 113(3):622–629. https://doi.org/10.3171/2009.11.JNS081052
Simard JM, Tsymbalyuk O, Ivanov A, Ivanova S, Bhatta S, Geng Z, Woo SK, Gerzanich V (2007) Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury. J Clin Invest 117(8):2105–2113. https://doi.org/10.1172/JCI32041
Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ (2010) HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28:367–388. https://doi.org/10.1146/annurev.immunol.021908.132603
Singer OC, Kurre W, Humpich MC, Lorenz MW, Kastrup A, Liebeskind DS, Thomalla G, Fiehler J, Berkefeld J, Neumann-Haefelin T, MR Stroke Study Group Investigators (2009) Risk assessment of symptomatic intracerebral hemorrhage after thrombolysis using DWI-ASPECTS. Stroke 40(8):2743–2748
Sommer CJ (2017) Ischemic stroke: experimental models and reality. Acta Neuropathol 133(2):245–261. https://doi.org/10.1007/s00401-017-1667-0
Song Q, Wang Y, Cheng Y, Liu J, Wei C, Liu M (2019) Serum uric acid and risk of hemorrhagic transformation in patients with acute ischemic stroke. J Mol Neurosci. https://doi.org/10.1007/s12031-019-01404-x
Sorby-Adams AJ, Vink R, Turner RJ (2018) Large animal models of stroke and traumatic brain injury as translational tools. Am J Physiol Regul Integr Comp Physiol 315(2):R165–R190
Spratt NJ, Fernandez J, Chen M, Rewell S, Cox S, van Raay L, Hogan L, Howells DW (2006) Modification of the method of thread manufacture improves stroke induction rate and reduces mortality after thread-occlusion of the middle cerebral artery in young or aged rats. J Neurosci Methods 155(2):285–290. https://doi.org/10.1016/j.jneumeth.2006.01.020
Strbian D, Engelter S, Michel P, Meretoja A, Sekoranja L, Ahlhelm FJ, Mustanoja S, Kuzmanovic I, Sairanen T, Forss N, Cordier M, Lyrer P, Kaste M, Tatlisumak T (2012) Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score. Ann Neurol 71(5):634–641. https://doi.org/10.1002/ana.23546
Su EJ, Fredriksson L, Geyer M, Folestad E, Cale J, Andrae J, Gao Y, Pietras K, Mann K, Yepes M, Strickland DK, Betsholtz C, Eriksson U, Lawrence DA (2008) Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 14(7):731–737. https://doi.org/10.1038/nm1787
Sun L, Zhou W, Mueller C, Sommer C, Heiland S, Bauer AT, Marti HH, Veltkamp R (2010) Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia. J Cereb Blood Flow Metab 30(9):1651–1660. https://doi.org/10.1038/jcbfm.2010.50
Sun MS, Jin H, Sun X, Huang S, Zhang FL, Guo ZN, Yang Y (2018) Free radical damage in ischemia-reperfusion injury: an obstacle in acute ischemic stroke after revascularization therapy. Oxid Med Cell Longev 2018:3804979. https://doi.org/10.1155/2018/3804979
Sung SF, Chen SC, Lin HJ, Chen YW, Tseng MC, Chen CH (2013) Comparison of risk-scoring systems in predicting symptomatic intracerebral hemorrhage after intravenous thrombolysis. Stroke 44(6):1561–1566. https://doi.org/10.1161/STROKEAHA.111.000651
Suofu Y, Clark JF, Broderick JP, Kurosawa Y, Wagner KR, Lu A (2012) Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion. Neuroscience 212:180–189. https://doi.org/10.1016/j.neuroscience.2012.03.036
Suzuki Y, Nagai N, Umemura K (2011) Novel situations of endothelial injury in stroke–mechanisms of stroke and strategy of drug development: intracranial bleeding associated with the treatment of ischemic stroke: thrombolytic treatment of ischemia-affected endothelial cells with tissue-type plasminogen activator. J Pharmacol Sci 116(1):25–29. https://doi.org/10.1254/jphs.10r27fm
Tai SH, Chen HY, Lee EJ, Chen TY, Lin HW, Hung YC, Huang SY, Chen YH, Lee WT, Wu TS (2010) Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia. J Pineal Res 49(4):332–341. https://doi.org/10.1111/j.1600-079X.2010.00797.x
Tan S, Wang D, Liu M, Zhang S, Wu B, Liu B (2014) Frequency and predictors of spontaneous hemorrhagic transformation in ischemic stroke and its association with prognosis. J Neurol 261(5):905–912. https://doi.org/10.1007/s00415-014-7297-8
Tanahashi N (2009) Thrombolysis by intravenous tissue plasminogen activator (t-PA)—current status and future direction. Brain Nerve 61(1):41–52
Tang YC, Tian HX, Yi T, Chen HB (2016) The critical roles of mitophagy in cerebral ischemia. Protein Cell 7(10):699–713. https://doi.org/10.1007/s13238-016-0307-0
Teng F, Beray-Berthat V, Coqueran B, Lesbats C, Kuntz M, Palmier B, Garraud M, Bedfert C, Slane N, Bérézowski V, Szeremeta F, Hachani J, Scherman D, Plotkine M, Doan BT, Marchand-Leroux C, Margaill I (2013) Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice. Exp Neurol 248:416–428. https://doi.org/10.1016/j.expneurol.2013.07.007
Terruso V, D’Amelio M, Di Benedetto N, Lupo I, Saia V, Famoso G, Mazzola MA, Aridon P, Sarno C, Ragonese P, Savettieri G (2009) Frequency and determinants for hemorrhagic transformation of cerebral infarction. Neuroepidemiology 33(3):261–265. https://doi.org/10.1159/000229781
Thomalla G, Sobesky J, Köhrmann M, Fiebach JB, Fiehler J, Zaro Weber O, Kruetzelmann A, Kucinski T, Rosenkranz M, Röther J, Schellinger PD (2007) Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours. Stroke 38(2):313–318. https://doi.org/10.1161/01.STR.0000254565.51807.22
Tietz S, Engelhardt B (2015) Brain barriers: crosstalk between complex tight junctions and adherens junctions. J Cell Biol 209(4):493–506. https://doi.org/10.1083/jcb.201412147
Tornabene E, Helms H, Pedersen SF, Brodin B (2019) Effects of oxygen-glucose deprivation (OGD) on barrier properties and mRNA transcript levels of selected marker proteins in brain endothelial cells/astrocyte co-cultures. PLoS ONE 14(8):e0221103. https://doi.org/10.1371/journal.pone.0221103
Tosun C, Kurland DB, Mehta R, Castellani RJ, deJong JL, Kwon MS, Woo SK, Gerzanich V, Simard JM (2013) Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage. Stroke 44(12):3522–3528. https://doi.org/10.1161/STROKEAHA.113.002904
Trouillas P, von Kummer R (2006) Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke. Stroke 37(2):556–561. https://doi.org/10.1161/01.STR.0000196942.84707.71
Tsivgoulis G, Zand R, Katsanos AH, Turc G, Nolte CH, Jung S, Cordonnier C, Fiebach JB, Scheitz JF, Klinger-Gratz PP, Oppenheim C, Goyal N, Safouris A, Mattle HP, Alexandrov AW, Schellinger PD, Alexandrov AV (2016) Risk of symptomatic intracerebral hemorrhage after intravenous thrombolysis in patients with acute ischemic stroke and high cerebral microbleed burden: a meta-analysis. JAMA Neurol 73(6):675–683. https://doi.org/10.1001/jamaneurol.2016.0292
Vales-Montero M, García-Pastor A, Iglesias-Mohedano AM, Esteban-de Antonio E, Salgado-Cámara P, García-Domínguez JM, Vázquez-Alén P, Díaz-Otero F, Fernández-Bullido Y, Gil-Núñez A (2019) Cerebral amyloid angiopathy-related transient focal neurological episodes: a transient ischemic attack mimic with an increased risk of intracranial hemorrhage. J Neurol Sci 406:116452. https://doi.org/10.1016/j.jns.2019.116452
Viswanathan A, Greenberg SM (2011) Cerebral amyloid angiopathy in the elderly. Ann Neurol 70(6):871–880. https://doi.org/10.1002/ana.22516
Walberer M, Rueger MA (2015) The macrosphere model-an embolic stroke model for studying the pathophysiology of focal cerebral ischemia in a translational approach. Ann Transl Med 3(9):123. https://doi.org/10.3978/j.issn.2305-5839.2015.04.02
Wang J (2010) Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog Neurobiol 92(4):463–477. https://doi.org/10.1016/j.pneurobio.2010.08.001
Wang R, Zeng J, Wang F, Zhuang X, Chen X, Miao J (2019) Risk factors of hemorrhagic transformation after intravenous thrombolysis with rt-PA in acute cerebral infarction. QJM 112(5):323–326. https://doi.org/10.1093/qjmed/hcy292
Wang W, Li M, Chen Q, Wang J (2015) Hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke: mechanisms, models, and biomarkers. Mol Neurobiol 52(3):1572–1579. https://doi.org/10.1007/s12035-014-8952-x
Wang W, Li M, Wang Y, Li Q, Deng G, Wan J, Yang Q, Chen Q, Wang J (2016) GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats. Mol Neurobiol 53(10):7028–7036. https://doi.org/10.1007/s12035-015-9607-2
Wang W, Li M, Wang Y, Wang Z, Zhang W, Guan F, Chen Q, Wang J (2017) GSK-3β as a target for protection against transient cerebral ischemia. Int J Med Sci 14(4):333–339. https://doi.org/10.7150/ijms.17514
Weston RM, Jones NM, Jarrott B, Callaway JK (2007) Inflammatory cell infiltration after endothelin-1-induced cerebral ischemia: histochemical and myeloperoxidase correlation with temporal changes in brain injury. J Cereb Blood Flow Metab 27(1):100–114. https://doi.org/10.1038/sj.jcbfm.9600324
Winkler EA, Bell RD, Zlokovic BV (2011) Central nervous system pericytes in health and disease. Nat Neurosci 14(11):1398–1405. https://doi.org/10.1038/nn.2946
Woloszynska I, Stfpien A (2017) Risk factors of rt-PA therapy in patients with ischemic stroke. Acta Pol Pharm 74(1):293–298
Won S, Lee JH, Wali B, Stein DG, Sayeed I (2014) Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway. J Cereb Blood Flow Metab 34(1):72–80. https://doi.org/10.1038/jcbfm.2013.163
Wu BN, Wu J, Hao DL, Mao LL, Zhang J, Huang TT (2018) High serum sICAM-1 is correlated with cerebral microbleeds and hemorrhagic transformation in ischemic stroke patients. Br J Neurosurg. https://doi.org/10.1080/02688697.2018.1518515
Wu X, Liu S, Hu Z, Zhu G, Zheng G, Wang G (2018) Enriched housing promotes post-stroke neurogenesis through calpain 1-STAT3/HIF-1α/VEGF signaling. Brain Res Bull 139:133–143. https://doi.org/10.1016/j.brainresbull.2018.02.018
Xing Y, Guo ZN, Yan S, Jin H, Wang S, Yang Y (2014) Increased globulin and its association with hemorrhagic transformation in patients receiving intra-arterial thrombolysis therapy. Neurosci Bull 30(3):469–476. https://doi.org/10.1007/s12264-013-1440-x
Yamashita T, Kamiya T, Deguchi K, Inaba T, Zhang H, Shang J, Miyazaki K, Ohtsuka A, Katayama Y, Abe K (2009) Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain. J Cereb Blood Flow Metab 29(4):715–725. https://doi.org/10.1038/jcbfm.2008.164
Yang C, Hawkins KE, Doré S, Candelario-Jalil E (2019b) Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol 316(2):C135–135C153. https://doi.org/10.1152/ajpcell.00136.2018
Yang JL, Yang YR, Chen SD (2019) The potential of drug repurposing combined with reperfusion therapy in cerebral ischemic stroke: A supplementary strategy to endovascular thrombectomy. Life Sci 236:116889. https://doi.org/10.1016/j.lfs.2019.116889
Yang N, Lin M, Wang BG, Zeng WY, He YF, Peng HY, Zeng J, Wu ZY, Zhong Y (2016) Low level of low-density lipoprotein cholesterol is related with increased hemorrhagic transformation after acute ischemic cerebral infarction. Eur Rev Med Pharmacol Sci 20(4):673–678
Yang Y, Rosenberg GA (2011) Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42(11):3323–3328. https://doi.org/10.1161/STROKEAHA.110.608257
Yao X, Wang Y, Zhang D (2018) microRNA-21 confers neuroprotection against cerebral ischemia-reperfusion injury and alleviates blood-brain barrier disruption in rats via the MAPK signaling pathway. J Mol Neurosci 65(1):43–53. https://doi.org/10.1007/s12031-018-1067-5
Yin B, Li DD, Xu SY, Huang H, Lin J, Sheng HS, Fang JH, Song JN, Zhang M (2019) Simvastatin pretreatment ameliorates t-PA-induced hemorrhage transformation and MMP-9/TIMP-1 imbalance in thromboembolic cerebral ischemic rats. Neuropsychiatr Dis Treat 15:1993–2002. https://doi.org/10.2147/NDT.S199371
Yin J, Liu YH, Xu YF, Zhang YJ, Chen JG, Shu BH, Wang JZ (2006) Melatonin arrests peroxynitrite-induced tau hyperphosphorylation and the overactivation of protein kinases in rat brain. J Pineal Res 41(2):124–129. https://doi.org/10.1111/j.1600-079X.2006.00343.x
Yong M, Kaste M (2008) Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial. Stroke 39(10):2749–2755. https://doi.org/10.1161/STROKEAHA.108.514307
Yu HL, Wang LZ, Zhang LL, Chen BL, Zhang HJ, Li YP, Xiao GD, Chen YZ (2019) ESE1 expression correlates with neuronal apoptosis in the hippocampus after cerebral ischemia/reperfusion injury. Neural Regen Res 14(5):841–849. https://doi.org/10.4103/1673-5374.249232
Yu X, Shi J, Jiang C, Xu J, You S, Cao Y, Liu C (2015) Association study of serum uric acid levels with clinical outcome and hemorrhagic transformation in stroke patients with rt-PA intravenous thrombolysis. Zhonghua Yi Xue Za Zhi 95(29):2351–2354
Zand R, Tsivgoulis G, Singh M, McCormack M, Goyal N, Ishfaq MF, Shahripour RB, Nearing K, Elijovich L, Alexandrov AW, Liebeskind DS, Alexandrov AV (2017) Cerebral microbleeds and risk of intracerebral hemorrhage post intravenous thrombolysis. J Stroke Cerebrovasc Dis 26(3):538–544. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.11.127
Zapata-Wainberg G, Masjuan J, Quintas S, Ximénez-Carrillo Á, García Pastor A, Martínez Zabaleta M, Cardona P, Freijo Guerrero MM, Llull L, Benavente Fernández L, Castellanos Rodrigo M, Egido J, Serena J, Vivancos J, Researchers in the ANITA-FA Study (2019) The neurologist’s approach to cerebral infarct and transient ischaemic attack in patients receiving anticoagulant treatment for non-valvular atrial fibrillation: ANITA-FA study. Eur J Neurol 26(2):230–237. https://doi.org/10.1111/ene.13792
Zhang FH, Lin YH, Huang HG, Sun JZ, Wen SQ, Lou M (2013) Rosiglitazone attenuates hyperglycemia-enhanced hemorrhagic transformation after transient focal ischemia in rats. Neuroscience 250:651–657. https://doi.org/10.1016/j.neuroscience.2013.07.039
Zhang J, Yang Y, Sun H, Xing Y (2014) Hemorrhagic transformation after cerebral infarction: current concepts and challenges. Ann Transl Med 2(8):81. https://doi.org/10.3978/j.issn.2305-5839.2014.08.08
Zhang L, Zhang ZG, Zhang C, Zhang RL, Chopp M (2004) Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model. Stroke 35(12):2890–2895. https://doi.org/10.1161/01.STR.0000147963.68238.da
Zhang ZG, Lü TS, Yuan HY (2011) Neuroprotective effects of ultra-low-molecular-weight heparin in vitro and vivo models of ischemic injury. Fundam Clin Pharmacol 25(3):300–303. https://doi.org/10.1111/j.1472-8206.2010.00845.x
Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Nv B, Chopp M (2000) VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106(7):829–838. https://doi.org/10.1172/JCI9369
Zhao BQ, Wang S, Kim HY, Storrie H, Rosen BR, Mooney DJ, Wang X, Lo EH (2006) Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12(4):441–445. https://doi.org/10.1038/nm1387
Zhao X, Wu T, Chang CF, Wu H, Han X, Li Q, Gao Y, Li Q, Hou Z, Maruyama T, Zhang J, Wang J (2015) Toxic role of prostaglandin E2 receptor EP1 after intracerebral hemorrhage in mice. Brain Behav Immun 46:293–310. https://doi.org/10.1016/j.bbi.2015.02.011
Zhao XJ, Larkin TM, Lauver MA, Ahmad S, Ducruet AF (2017) Tissue plasminogen activator mediates deleterious complement cascade activation in stroke. PLoS ONE 12(7):e0180822. https://doi.org/10.1371/journal.pone.0180822
Zhao YN, Wang F, Fan YX, Ping GF, Yang JY, Wu CF (2013) Activated microglia are implicated in cognitive deficits, neuronal death, and successful recovery following intermittent ethanol exposure. Behav Brain Res 236(1):270–282. https://doi.org/10.1016/j.bbr.2012.08.052
Zhu HB, Wang ZH, Tian JW, Fu FH, Liu K, Li CL (2005) Protective effect of hydroxysafflor yellow A on experimental cerebral ischemia in rats. Yao Xue Xue Bao 40(12):1144–1146
Zhu Z, Fu Y, Tian D, Sun N, Han W, Chang G, Dong Y, Xu X, Liu Q, Huang D, Shi FD (2015) Combination of the immune modulator fingolimod with alteplase in acute ischemic stroke: a pilot trial. Circulation 132(12):1104–1112. https://doi.org/10.1161/CIRCULATIONAHA.115.016371